FAT1-decorated OMVs
FAT1-OMV immunization
testing FAT1-OMV
scalable FAT1-OMV production
subcutaneous growth of FAT1
cancer models
colorectal cancer immunotherapy
positive CT26 cancer cells
unique adjuvanticity properties of bacterial Outer Membrane Vesicles
T cells
present proposal
recent results
promising results
checkpoint inhibitor combination
tumour infiltration of CD4
metastatic colorectal cancers
protective activity of checkpoint inhibitors
CD8
purification process
protection
concomitant decrease of Treg
innovative vaccines
immunocompetent mice
course
increase
demonstration
Advanced ERC Project
OMVac
main objectives
CRC
clinical setting
infectious diseases
submission
antigen
development
MDSCs
Synthetic Biology
scope